Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Cody B Jackson

3PUBLICATIONS

11CO-AUTHORS

Medical molecular engineering of nucleic acids and proteinsEmergency medicine

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Oct 11, 2023

Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability.

Lizhou Zhang, Kunal R More, Amrita Ojha

|Oct 06, 2021

Mechanisms of SARS-CoV-2 entry into cells.

Cody B Jackson, Michael Farzan, Bing Chen

|Nov 27, 2020

SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity.

Lizhou Zhang, Cody B Jackson, Huihui Mou

Pageof 1

Frequent Collaborators

3 joint publications

Hyeryun Choe

2 joint publications

Michael Farzan

1 joint publications

Haiyong Peng

1 joint publications

Wenhui Li

1 joint publications

Tina Izard

1 joint publications

Christoph Rader

1 joint publications

Bing Chen

1 joint publications

Lizhou Zhang

1 joint publications

Kunal R More

1 joint publications

Hao Li

Frequent Collaborators

3 joint publications

Hyeryun Choe

2 joint publications

Michael Farzan

1 joint publications

Haiyong Peng

1 joint publications

Wenhui Li

Top Related Videos

Testing the <em>In Vitro</em> and <em>In Vivo</em> Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Testing the <em>In Vitro</em> and <em>In Vivo</em> Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on : Jan 20, 2023

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles <em>In Vitro</em>

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles <em>In Vitro</em>

Published on : Jun 06, 2025

See more related videos

Top Related Videos

Testing the <em>In Vitro</em> and <em>In Vivo</em> Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Testing the <em>In Vitro</em> and <em>In Vivo</em> Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on : Jan 20, 2023

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles <em>In Vitro</em>

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles <em>In Vitro</em>

Published on : Jun 06, 2025

See more related videos